Sun Yat-sen University Cancer Center for International Patients
Sun Yat-sen University Cancer Center (SYSUCC) is a major public academic cancer center in Guangzhou with disease-specific surgery, medical oncology, radiation oncology, pathology, molecular diagnosis, nuclear medicine, interventional treatment and clinical-trial infrastructure. It is especially relevant for nasopharyngeal, breast, lung/thoracic, colorectal, gastric, liver, pancreaticobiliary, urologic, gynecologic and other difficult cancers.
Quick answer: SYSUCC is one of the strongest Guangzhou options when the case needs a dedicated
oncology center rather than a general hospital. It now publishes a dedicated International Medical Center with
international outpatient and inpatient contacts. For overseas patients, the practical first step is still to send
the diagnosis, pathology, imaging and treatment history before buying flights, because pre-arrival review can
confirm whether treatment appears possible but does not guarantee the final treatment plan.
✓ Dedicated public cancer center
✓ Current International Medical Center
✓ Disease-specific oncology routing
✓ No guaranteed treatment or outcome
SYSUCC at a Glance
Established in 1964 and affiliated with Sun Yat-sen University, SYSUCC operates major campuses in Yuexiu and Huangpu. Its institutional profile describes a large integrated cancer-care, research, prevention and education platform with dozens of disease-specific clinical departments.
Hospital type
Dedicated public academic cancer center affiliated with Sun Yat-sen University.
Main campuses
Yuexiu and Huangpu; some departments are campus-specific.
Institution-reported scale
2023 profile: 2,247 beds, 42 operating rooms and 35 clinical departments.
International access
Dedicated International Medical Center with published outpatient/inpatient contacts.
Service-volume and infrastructure figures are institution-reported scale indicators, not proof of better outcomes for an individual patient.
When SYSUCC Is a Strong Hospital to Consider
A solid tumor needs disease-specific staging and treatment planning
SYSUCC is organized around cancer-specific departments, making it useful when surgery, radiation, systemic treatment, pathology and imaging need to be coordinated within one oncology center.
The case needs MDT review or another treatment sequence
Patients with recurrence, borderline operability, previous radiation or multiple prior systemic therapies may benefit from a multidisciplinary oncology review rather than a single-procedure referral.
Trial, molecular or precision-oncology review is relevant
SYSUCC has a Clinical Trial Center, molecular diagnosis, pathology, nuclear medicine and disease-specific research programs. Trial eligibility must still be checked protocol by protocol.
SYSUCC is not automatically the best Chinese hospital for every cancer. A hematologic/CAR-T case may
fit Ruijin better; a complex brain tumor may need a dedicated neuro center; and some international patients may
prefer Fuda because its logistics pathway is more explicitly designed around overseas cancer patients.
Major Cancer Programs at SYSUCC
| Cancer area | Why SYSUCC may be relevant | Questions to ask before travel |
|---|---|---|
| Nasopharyngeal carcinoma | Dedicated NPC department plus major radiation-oncology and precision-research programs. | Stage, EBV markers, radiation plan, chemotherapy need, recurrence route, previous radiation and whether research findings apply clinically. |
| Breast cancer | Dedicated Breast Oncology with surgery, systemic treatment, radiation, pathology and molecular support. | Subtype, stage, neoadjuvant therapy, breast conservation, reconstruction, radiation and systemic-treatment sequencing. |
| Lung / thoracic cancer | Thoracic Surgery + Medical Oncology + Radiation Oncology + Molecular Diagnosis + pathology and clinical trials. | Operability, molecular testing, targeted/immunotherapy, chemoradiation and recurrence strategy. |
| Colorectal / gastric cancer | Disease-specific colorectal and gastric surgical teams with systemic and radiation oncology support. | Resectability, neoadjuvant treatment, organ-preservation question, peritoneal/liver metastases and molecular status. |
| Liver cancer | Dedicated liver surgery with interventional, medical-oncology, radiation and imaging support. | Resectability, local treatment, systemic therapy, vascular invasion and whether transplant should be evaluated elsewhere. |
| Pancreatic / biliary cancer | Dedicated Pancreaticobiliary Surgery at Huangpu plus multidisciplinary oncology. | Resectability, vascular involvement, neoadjuvant treatment, pathology and surgical-risk assessment. |
| Urologic cancers | Urology plus radiation, medical oncology, pathology and nuclear medicine. | Risk/stage, surgery vs radiation, metastatic treatment, molecular testing and nuclear-medicine relevance. |
| Gynecologic cancers | Dedicated Gynecologic Oncology with surgery, systemic treatment and radiation support. | Stage, surgical candidacy, fertility preservation when relevant, chemotherapy and radiotherapy plan. |
Nasopharyngeal Carcinoma: A Signature SYSUCC Program
Nasopharyngeal carcinoma (NPC) is one of the clearest reasons to consider SYSUCC. The hospital has a dedicated NPC department, major head-and-neck/radiation infrastructure and a long research record in an area that is particularly important in Southern China.
Clinical questions that fit SYSUCC
- Newly diagnosed non-metastatic NPC
- Radiation planning and systemic-treatment sequencing
- Locally advanced disease
- Persistent or recurrent disease after radiotherapy
- Second-opinion review of staging or target definition
- Clinical-trial relevance
Current research context
In 2025 SYSUCC teams co-led international NPC radiotherapy target-volume guidelines published in The Lancet Oncology. In March 2026 a SYSUCC-led team reported a Nature study using dynamic ctDNA for risk-adaptive treatment, and in April 2026 another Nature paper examined EBV-strain/HLA interactions in NPC risk.
These are research achievements. They do not mean every patient receives an experimental adaptive protocol.
Breast Cancer at SYSUCC
SYSUCC has a dedicated Breast Oncology department supported by pathology, molecular diagnosis, medical oncology, radiation oncology and imaging. For an international patient, the value is the ability to route the case by tumor biology and stage rather than treating “breast cancer” as one uniform disease.
Surgery and local-control planning
- Breast conservation vs mastectomy
- Sentinel / nodal strategy
- Reconstruction discussion
- Adjuvant radiation question
Systemic treatment before surgery
- HER2 status
- Hormone receptor status
- Triple-negative disease
- Response-based surgery planning
Biology-driven systemic therapy
- Previous treatment sequence
- Metastatic sites
- Molecular testing
- Trial relevance
Related: Breast Cancer Treatment in China.
Lung and Thoracic Cancer at SYSUCC
SYSUCC’s thoracic route combines Thoracic Surgery with Medical Oncology, Radiation Oncology, Molecular Diagnosis, Pathology, Nuclear Medicine and clinical-trial infrastructure. The official thoracic department describes a focus on lung cancer, esophageal cancer and mediastinal tumors.
Thoracic surgery
Relevant when the central question is whether the tumor can be resected, how much lung/esophagus must be removed and whether systemic treatment should be given before or after surgery.
Targeted and immune treatment
Molecular diagnosis matters particularly in advanced non-small-cell lung cancer, where driver alterations and immune biomarkers can change treatment selection.
Radiation + systemic treatment
Locally advanced or recurrent thoracic cancers may need coordinated chemoradiation, systemic treatment or stereotactic/local approaches rather than surgery alone.
Related: Lung Cancer Treatment in China.
Colorectal, Gastric, Liver and Pancreaticobiliary Cancer
SYSUCC has separate colorectal, gastric, liver and pancreaticobiliary surgical departments rather than one broad abdominal-surgery service. That matters because treatment sequencing and operability differ substantially by organ, tumor biology and metastatic pattern.
Colorectal
Resection, rectal-cancer strategy, metastasis review, systemic treatment and multidisciplinary sequencing.
Gastric
Staging, surgical candidacy, perioperative systemic therapy and complex recurrence.
Liver
Surgery, interventional treatment, systemic therapy, radiation and imaging-defined resectability.
Pancreaticobiliary
Complex pancreatic and biliary surgery at Huangpu with multidisciplinary treatment planning.
Liver cancer does not automatically mean SYSUCC is the only hospital to consider. If the case
includes end-stage liver disease or a real transplant question, compare a transplant-focused center such as Renji
or FAH-SYSU rather than assuming a cancer-only pathway is sufficient.
Related: Liver Cancer Treatment in China.
Radiation Oncology at SYSUCC
Radiation Oncology is one of SYSUCC’s central platforms. The hospital’s current department page describes treatment across nasopharyngeal and other head-and-neck cancers, lung, esophageal, breast, gynecologic, rectal cancer, lymphoma and other malignancies.
Why the radiation team matters
- Definitive radiation for tumors where surgery is not first-line
- Postoperative radiation
- Concurrent chemoradiation
- Stereotactic/local treatment questions
- Re-irradiation assessment after previous radiotherapy
- Target-volume review in difficult head-and-neck cases
Send old radiation records
- Previous dose and fractions
- Radiation plan / DICOM-RT when available
- Fields and organs-at-risk summary
- Treatment dates
- Response and late toxicity history
- Current imaging showing recurrence
Pathology, Molecular Diagnosis and Nuclear Medicine
Advanced cancer treatment depends on diagnosis quality. SYSUCC combines a dedicated Pathology Department with Molecular Diagnosis and Nuclear Medicine, allowing imaging, tumor classification, molecular markers and theranostic questions to be evaluated within the same cancer-center system.
Confirm the tumor
Pathology re-review can matter when the diagnosis is rare, the subtype is uncertain or treatment depends on immunohistochemistry.
Find actionable biology
Molecular testing may change systemic treatment or trial selection in lung, colorectal, breast, ovarian and other cancers.
Imaging and theranostics
SYSUCC’s nuclear-medicine department describes cancer theranostics as a core area, but the exact diagnostic or therapeutic radiopharmaceutical must be confirmed case by case.
Clinical Trials at SYSUCC
SYSUCC has a dedicated Clinical Trial Center and a public recruitment portal. The center describes hospital-wide trial management, ethics and quality-control functions plus a Phase I unit.
Find the exact protocol
Trial name, protocol number, phase, cancer subtype, biomarker and recruitment status must all match the patient’s case.
Check medical eligibility
Previous drugs, measurable disease, organ function, performance status and washout periods commonly affect eligibility.
Check international practicality
Foreign-patient participation, repeated visits, local tests, accommodation and follow-up requirements must be confirmed before travel.
A trial listing is not a treatment offer. Do not travel because a drug or protocol appears on a
hospital website. Confirm that the exact study is recruiting and that the study team has reviewed the patient’s
records.
SYSUCC International Medical Center
SYSUCC now publishes a dedicated International Medical Center rather than relying only on the standard outpatient route. The center is designed for foreign patients, Hong Kong/Macao/Taiwan residents and other patients seeking an internationally oriented cancer-care service.
Dedicated international scheduling
Published model: specialty scheduling plus appointment with a preferred physician, including senior disease-specific specialists and principal investigators.
Dual clinical supervision
SYSUCC describes inpatient care as a dual-supervision model involving the disease department and an attending professor, while the International Medical Center coordinates ongoing care.
International coordination
The center publishes dedicated consulting/examination areas and premium wards, with a team of physicians and specialized nurses supporting the patient journey.
Published International Medical Center contacts:
International Outpatient: +86-20-87342620 (1st Floor, Building 1) / +86-20-87341976 (20th Floor, Building 2)
International Inpatient: +86-20-87342525
Email: gjylb@sysucc.org.cn
International Outpatient: +86-20-87342620 (1st Floor, Building 1) / +86-20-87341976 (20th Floor, Building 2)
International Inpatient: +86-20-87342525
Email: gjylb@sysucc.org.cn
Pre-Arrival Medical Record Review
SYSUCC’s International Office publishes a useful distinction for overseas patients: it can review medical files before arrival to assess whether treatment may be possible, but it states that it cannot issue a treatment plan before the patient arrives in China.
What pre-arrival review can help answer
- Does SYSUCC treat this cancer type?
- Which department should receive the case?
- Is an in-person visit potentially useful?
- Are more records needed before arrival?
- Can the hospital explain admission/visa procedures?
What not to assume
- No guaranteed final treatment plan before arrival
- No guaranteed admission date until confirmed
- No guaranteed trial eligibility
- No guaranteed procedure or drug availability
- No guaranteed cost until the treatment pathway is defined
International Office email published by SYSUCC: contact@sysucc.org.cn.
Appointments: Chinese Phone Requirement and International Route
SYSUCC states that outpatient visits are conducted on a 100% appointment basis. Its standard APP and WeChat registration routes require a Chinese mobile-phone number, which can create friction for a patient who is still abroad.
Practical implication: an overseas patient should not assume that the normal Chinese outpatient
booking workflow is the easiest route. The dedicated International Medical Center contacts may be more practical
for foreign-patient intake and department coordination.
Prepare records
Pathology, imaging, stage, previous treatment and current symptoms.
Identify the disease department
Breast, thoracic, NPC, liver, colorectal, urology, gynecology and other cancers use different teams.
Request pre-arrival review
Confirm whether treatment may be possible and what additional documents are required.
Confirm logistics
Appointment, campus, language support, deposit/payment, admission plan and expected stay.
Medical Documents and Translation
SYSUCC explicitly states that medical documents are issued in Chinese and that it does not translate medical
files from Chinese into English. This matters for continuity of care after returning home.
Before treatment
Ask what language SYSUCC accepts for incoming pathology, imaging and previous-treatment records. If translation is required, use accurate medical translation rather than relying on informal summaries.
Before discharge
Request copies of pathology, imaging reports, operation notes, drug schedules, radiation summary and discharge documentation, then arrange certified or medically competent translation for your home medical team if needed.
SYSUCC Yuexiu and Huangpu Campuses
SYSUCC operates two main clinical campuses. The official hospital profile states that many departments work across both sites, while some are campus-specific.
651 Dongfeng East Road, Yuexiu District, Guangzhou
The long-established central campus. SYSUCC’s English location page lists 651 Dongfeng East Road, Guangzhou 510060. Neurosurgery is listed as Yuexiu-only in the current campus overview.
Major newer oncology campus
Huangpu opened in 2021 and houses major surgical and oncology services. The hospital currently lists Bone and Soft Tissue Surgery, Hematological Oncology, Molecular Diagnosis and Pancreaticobiliary Surgery as Huangpu-only.
Confirm the campus before booking a hotel. The first consultation, imaging, surgery, radiation,
inpatient admission or specialist department may not all be located at the same site.
SYSUCC Costs for International Patients
There is no trustworthy universal international SYSUCC price for “cancer treatment.” The final cost
depends on diagnosis, stage, pathology and molecular testing, surgery, radiation, systemic drugs, nuclear medicine,
hospitalization and International Medical Center service level.
Diagnostics
Pathology review, molecular testing, CT/MRI/PET, endoscopy and repeat biopsy can change the final plan and bill.
Treatment
Surgery, radiation, chemotherapy, targeted therapy, immunotherapy and interventional/nuclear-medicine treatment have different cost structures.
International service
Premium ward, coordination and other International Medical Center services can affect the final amount.
Ask for a written estimate after the relevant department has reviewed the records. The estimate should separate confirmed items from costs that depend on additional tests after arrival.
Related: Cancer Treatment Cost in China.
What Records Should You Send for a SYSUCC Review?
Core oncology file
- Diagnosis and pathology report
- Pathology slides / digital pathology if available
- Recent CT / MRI / PET reports
- DICOM imaging files
- Current stage and metastatic sites
- Operation and radiation summaries
- Current medication list and allergies
For advanced or recurrent disease
- Complete systemic-treatment history with dates
- Response / progression after each line
- Relevant molecular and genetic results
- Recent blood count, liver and kidney function
- Performance status / current symptoms
- Previous radiation dose/plan if re-irradiation may be considered
- Your exact question for the SYSUCC team
SYSUCC vs Fuda and FUSCC
| Hospital | Typical strengths | International-access profile | When it may fit best |
|---|---|---|---|
| SYSUCC | Dedicated public academic oncology, NPC, radiation, disease-specific surgery, pathology, molecular diagnosis, nuclear medicine and trials. | Current International Medical Center + International Office pre-arrival file review. | When the case needs a large disease-specific public cancer center in Guangzhou. |
| Fuda Cancer Hospital | Cancer-focused hospital with selected interventional/local treatment programs. | Long-standing, explicit international-patient logistics including record submission and travel coordination. | When overseas intake/logistics are especially important or a Fuda-specific technique is being evaluated. |
| FUSCC Shanghai | Major public academic solid-tumor center with surgery, radiation, medical oncology, pathology and research. | Strong oncology platform; current overseas self-pay pathway is less clearly published than SYSUCC’s new International Medical Center. | When the disease program or Shanghai specialist team better matches the case. |
Related: Hospitals in Guangzhou and Best Cancer Hospitals in China.
Send the Cancer Records Before Booking Guangzhou
We’ll check whether SYSUCC is a strong match for the cancer type and treatment question, compare it with Fuda, FUSCC or another China center when useful, and identify what should be confirmed before travel.
✓ Cancer-type matching
✓ International route checked before travel
✓ No obligation to book
Frequently Asked Questions
Direct answers to the main questions international patients ask about SYSUCC before planning cancer treatment in Guangzhou.
Can international patients be treated at Sun Yat-sen University Cancer Center?
Yes. SYSUCC now publishes a dedicated International Medical Center for foreign patients and other patients seeking internationally oriented cancer services. The center provides international outpatient and inpatient contacts, specialist scheduling, premium wards and full-cycle coordination. Acceptance still depends on the diagnosis, treatment question, physician availability and whether the relevant department can take the case.
What cancers is SYSUCC strongest for?
SYSUCC is a dedicated cancer center with disease-specific departments for breast cancer, thoracic and lung cancer, nasopharyngeal carcinoma, colorectal cancer, gastric cancer, liver cancer, pancreatic and biliary tumors, urologic cancers, gynecologic cancers, pediatric oncology, hematologic oncology, head and neck tumors, bone and soft-tissue tumors and other cancers. It also has medical oncology, radiation oncology, pathology, molecular diagnosis, nuclear medicine and a Clinical Trial Center.
Is SYSUCC especially strong for nasopharyngeal carcinoma?
Yes. Nasopharyngeal carcinoma is one of SYSUCC’s signature disease programs. The center has a dedicated Nasopharyngeal Carcinoma Department and major radiation-oncology expertise. In 2025 and 2026 SYSUCC teams also reported major international work on NPC radiotherapy guidelines, dynamic ctDNA-guided risk adaptation and EBV-related disease biology. Research results should not be treated as automatically available standard treatment for every patient.
Does SYSUCC treat lung cancer?
Yes. SYSUCC has Thoracic Surgery, Medical Oncology, Radiation Oncology, Molecular Diagnosis, Pathology, Nuclear Medicine and Clinical Trial Center services relevant to lung cancer. The treatment route can include surgery, radiotherapy, targeted therapy, immunotherapy or combinations depending on stage, pathology, molecular results and previous treatment.
Can SYSUCC review my medical records before I fly to China?
SYSUCC states that its International Office can review medical files before arrival to assess whether treatment may be possible. It also states that it cannot provide a treatment plan before the patient arrives in China. Treat pre-arrival review as an acceptance and routing step, not as a guaranteed final plan.
Can I book SYSUCC using WeChat from outside China?
The standard SYSUCC outpatient system is appointment-only, but the hospital states that its APP and WeChat registration require a Chinese mobile-phone number. Overseas patients may find the dedicated International Medical Center contacts more practical than relying on the standard registration route.
Does SYSUCC provide English medical reports?
SYSUCC’s international-patient guide states that medical documents such as examination results and discharge materials are issued in Chinese and that the hospital does not translate medical files from Chinese to English. If you need English documentation for your home doctor or insurer, arrange translation separately and confirm what source documents the hospital can provide.
Can international patients join clinical trials at SYSUCC?
SYSUCC has a dedicated Clinical Trial Center and a public recruitment portal, but having an active trial does not mean an overseas patient is eligible. Eligibility depends on the exact protocol, cancer subtype, biomarkers, stage, previous treatments, organ function, recruitment status and practical follow-up requirements. Confirm foreign-patient eligibility before travel.
How much does cancer treatment at SYSUCC cost for an international patient?
SYSUCC does not publish one universal international cancer-treatment package price that can be safely applied to every diagnosis. Costs depend on pathology and molecular testing, imaging, surgery, radiotherapy, systemic drugs, nuclear medicine, hospitalization, intensive care and International Medical Center service level. Request a written case-specific estimate after the relevant team reviews the records.
Is SYSUCC better than Fuda Cancer Hospital or FUSCC Shanghai?
They serve different referral needs. SYSUCC is a large public academic cancer center with deep disease-specific oncology and a new International Medical Center. Fuda has a long-standing, highly explicit international-patient logistics pathway and selected interventional/local treatment programs. FUSCC in Shanghai is another major public academic cancer center with strong solid-tumor oncology and research. The best choice depends on cancer type, stage, required treatment, trial relevance and practical access.
Sources and Verification
- Sun Yat-sen University Cancer Center — official English homepage. Current institutional identity, Guangzhou location, affiliated university and active 2026 news. SYSUCC official English website.
- SYSUCC — Institutional Introduction. Two operational campuses, 2,247 beds, 42 operating rooms, 35 clinical departments, 2023 service scale, national clinical specialty status and research platform. Page updated May 2024; scale figures are treated as institution-reported background, not outcome evidence. SYSUCC Introduction.
- SYSUCC — International Medical Center. Current dedicated international outpatient/inpatient service, specialist scheduling model, premium wards, full-cycle coordination and contact details. SYSUCC International Medical Center.
- SYSUCC — Guide for International Patients. Current appointment-only outpatient system, Chinese-phone requirement for APP/WeChat registration and international-patient documentation guidance. SYSUCC International Patient Guide.
- SYSUCC — Patient Care / International Office. International Office can provide visa/admission explanations, review medical files before arrival to assess treatment possibility and provide practical guidance; SYSUCC states it cannot provide a treatment plan before arrival and does not translate medical files from Chinese to English. SYSUCC Patient Care.
- SYSUCC — Medical Departments. Current directory supporting breast, thoracic, colorectal, gastric, gynecologic, liver, pancreaticobiliary, urologic, pediatric, hematologic, NPC, radiation, pathology, molecular diagnosis, nuclear medicine and other cancer programs. SYSUCC Medical Departments.
- SYSUCC — Clinical Trial Center. Clinical-trial management, Phase I unit, GCP functions and public trial-recruitment portal. SYSUCC Clinical Trial Center.
- SYSUCC — Thoracic Surgery. Official department description supporting lung cancer, esophageal cancer, mediastinal tumors and multidisciplinary thoracic oncology. SYSUCC Thoracic Surgery.
- SYSUCC — Nasopharyngeal Carcinoma Department. Dedicated NPC department, radiotherapy/chemotherapy/surgical management and research in diagnosis, stratified treatment, recurrence and late effects. SYSUCC Nasopharyngeal Carcinoma.
- SYSUCC — Radiation Oncology. Official department scope across NPC/head and neck, lung, esophageal, breast, gynecologic, rectal cancer, lymphoma and other malignancies. Department-scale figures are hospital-published background information. SYSUCC Radiation Oncology.
- SYSUCC — Nuclear Medicine. Official description of nuclear-medicine diagnostics, therapy and cancer theranostics. SYSUCC Nuclear Medicine.
- SYSUCC — Pathology. Anatomic pathology, cytopathology, immunohistochemistry, cytogenetics and molecular-pathology support. The detailed department page contains older staffing/volume data, so only the current service scope is used here. SYSUCC Pathology.
- SYSUCC — Pancreaticobiliary Surgery. Dedicated Huangpu-based pancreatic and biliary surgery department and complex surgical scope. SYSUCC Pancreaticobiliary Surgery.
- SYSUCC — Yuexiu location. Official address: 651 Dongfeng East Road, Yuexiu District, Guangzhou 510060. SYSUCC Location.
- SYSUCC — Huangpu Campus opening. Huangpu opened in 2021 with dedicated surgical/oncology departments including thoracic, pancreaticobiliary, colorectal, gastric, urology, breast, medical oncology, radiation oncology, NPC, hematologic oncology and bone/soft tissue services. SYSUCC Huangpu Campus.
- SYSUCC — International NPC radiotherapy guidelines, October 2025. SYSUCC teams co-led international target-volume delineation guidelines published in The Lancet Oncology. Used here as evidence of current research leadership, not as a treatment guarantee. NPC radiotherapy guidelines.
- SYSUCC — Nature NPC precision-treatment research, March 12, 2026. SYSUCC researchers reported risk-adaptive treatment research guided by dynamic ctDNA in nasopharyngeal carcinoma. Cited as research activity only. SYSUCC NPC ctDNA research 2026.
- SYSUCC — Nature EBV/HLA NPC research, April 20, 2026. Current SYSUCC report on EBV-strain and host-HLA interactions in nasopharyngeal carcinoma risk. Cited as research context, not as a clinical-test or treatment recommendation. SYSUCC EBV/HLA NPC research 2026.
Evidence rule: current international-access claims use SYSUCC’s International Medical Center and International Office pages. Older detailed department pages are used only for stable program scope where the hospital has not published newer department descriptions. Research publications are clearly separated from standard clinical availability and foreign-patient eligibility.
Last evidence check: September 2026. International contacts, physician schedules, campus assignments, clinical-trial recruitment, drug/device availability, insurance arrangements and prices can change; reconfirm before travel.
Check the Cancer Program and International Route First
Send pathology, imaging, stage and treatment history. We’ll check whether SYSUCC is medically appropriate, identify the likely department and compare another Chinese cancer center when that would better serve the case.